Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print January 9, 2008
DOI: 10.2337/db07-0595

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0595v1
db07-0595v2
57/4/846    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Martinez, S. C.
Right arrow Articles by Permutt, M. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, S. C.
Right arrow Articles by Permutt, M. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Inhibition of Foxo1 Protects Pancreatic Islet ®-Cells Against Fatty Acid and ER-Stress Induced Apoptosis

Sara C. Martinez1, Katsuya Tanabe1, Corentin Cras-Méneur1, Nada A. Abumrad2, Ernesto Bernal-Mizrachi1, and M. Alan Permutt1

1 Division of Endocrinology, Metabolism, and Lipid Research,
2 Department of Medicine, Division of Nutritional Science, Washington University School of Medicine, St. Louis, MO

Objective: β-cells are particularly susceptible to fatty acid (FA) induced apoptosis associated with decreased insulin receptor/PI3-kinase/Akt signaling and the activation of stress kinases. We examined the mechanism of FA induced apoptosis of mouse â-cells especially as related to the role played by ER stress-induced Foxo1 activation and whether decreasing Foxo1 activity could enhance cell survival.

Research Design and Methods: Mouse insulinoma (MIN6) cells were treated with FA and the role of Foxo1 in mediating effects on signaling pathways and apoptosis was examined by measuring Foxo1 activity and using dominant negative Foxo1.

Results: Increasing FA concentrations (100-400 µM palmitate or oleate) led to early Jun-N-terminal kinase (JNK) activation that preceded induction of ER stress markers and apoptosis. Foxo1 activity was increased with FA treatment and by pharmacologic inducers of ER-stress and this increase was prevented by JNK inhibition. FA induced nuclear localization of Foxo1 at 4 hours when Akt activity was increased indicating that FoxO1 activation was not mediated by JNK inhibition of Akt. In contrast, FA treatment for 24 hours was associated with decreased insulin signaling. A dominant-negative Foxo1 adenovirus (Adv-DNFoxo) conferred cells with protection from ER stress and FA mediated apoptosis. Microarray analysis revealed that FA induction of gene expression was in most cases reversed by Adv-DNFoxo, including the pro-apoptotic transcription factor, CHOP.

Conclusions: Early induction of JNK and Foxo1 activation play an important role in FA-induced apoptosis. Expressing a dominant-negative allele of Foxo1 reduces expression of apoptotic and ER stress markers and promotes β-cell survival from FA and ER-stress, identifying a potential therapeutic target for preserving β-cells in type 2 diabetes.


Correspondence: apermutt{at}im.wustl.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.